Trustmark National Bank Trust Department’s Quest Diagnostics DGX Stock Holding History

Trustmark National Bank Trust Department’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-390	Closed	-$40K	–	320
2019 Q2	$40K	Hold	390	–	–	﹤0.01%	377
2019 Q1	$35K	Hold	390	–	–	﹤0.01%	380
2018 Q4	$32K	Hold	390	–	–	﹤0.01%	376
2018 Q3	$42K	Buy	+390	New	+$42.8K	﹤0.01%	380
2017 Q3	–	Sell	-13,411	Closed	-$1.49M	–	262
2017 Q2	$1.49M	Sell	13,411 -300	-2%	-$31.7K	0.17%	113
2017 Q1	$1.35M	Buy	13,711 +286	+2%	+$27.3K	0.16%	111
2016 Q4	$1.23M	Buy	13,425 +2,125	+19%	+$183K	0.16%	118
2016 Q3	$956K	Buy	11,300 +420	+4%	+$35.3K	0.12%	142
2016 Q2	$886K	Buy	10,880 +195	+2%	+$14.8K	0.11%	142
2016 Q1	$763K	Buy	+10,685	New	+$717K	0.1%	147
2014 Q2	–	Sell	-4,049	Closed	-$235K	–	345
2014 Q1	$235K	Buy	4,049 +21	+0.5%	+$1.13K	0.03%	316
2013 Q4	$215K	Buy	4,028 +28	+0.7%	+$1.66K	0.03%	313
2013 Q3	$247K	Hold	4,000	–	–	0.03%	288
2013 Q2	$243K	Buy	+4,000	New	+$238K	0.03%	280

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Trustmark National Bank Trust Department's DGX Position: Q3 2019 in Review

Trustmark National Bank Trust Department sold out of Quest Diagnostics (DGX) in Q3 2019, closing a stake of 390 shares — an estimated $40K sold.

Trustmark National Bank Trust Department first reported a position in DGX in Q2 2013 and held it in 14 quarters. The position peaked at $1.49M in Q2 2017. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

Trustmark National Bank Trust Department reported no remaining Quest Diagnostics position as of Q3 2019 after selling out during the quarter.
Trustmark National Bank Trust Department sold 390 Quest Diagnostics shares in Q3 2019, an estimated $40K.
Trustmark National Bank Trust Department first reported a position in Quest Diagnostics in Q2 2013 and held it in 14 quarters.
Trustmark National Bank Trust Department's Quest Diagnostics position peaked at $1.49M in Q2 2017.
677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2019, filed 14 Nov 2019.